Overview

Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.

Status:
Completed

Trial end date:
2013-02-01

Target enrollment:

Participant gender:

Summary

The main purpose of the study is to compare the change of the AZD5069 Pharmacokinetic profile when administered with ketoconazole. Subjects will be treated first with AZD5069 only followed by a washout period before starting with the combined treatment (both ketoconazole and AZD5069).

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca

Treatments:

Ketoconazole